{
  "id": "5cb380b8ecadf2e73f00005d",
  "type": "yesno",
  "question": "Is the crystal structure of Pim-1 available?",
  "ideal_answer": "Yes,\nThe crystal structures of Pim1 in apo form and bound with AMPPNP have been solved",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/15808862",
    "http://www.ncbi.nlm.nih.gov/pubmed/30033129",
    "http://www.ncbi.nlm.nih.gov/pubmed/16227208",
    "http://www.ncbi.nlm.nih.gov/pubmed/22339127",
    "http://www.ncbi.nlm.nih.gov/pubmed/25575657",
    "http://www.ncbi.nlm.nih.gov/pubmed/23936194",
    "http://www.ncbi.nlm.nih.gov/pubmed/22926267"
  ],
  "snippets": [
    {
      "text": "Recent crystallographic studies of Pim-1 have identified unique structural features but have not provided insight into how the kinase recognizes its target substrates. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/16227208",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "a co-crystal structure of lead molecule (HS38) in complex with DAPK3, a dual Pim/DAPK3 inhibitor (HS56)",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/30033129",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The crystal structure of this compound with PIM1 confirmed the predicted binding mode and protein-ligand interactions except those in the acidic ribose pocket. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25575657",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Using the determined X-ray crystal structure of PIM1 complexed to the compound 1-R as a control, we discuss the importance of including the protein flexibility inherent in the ensemble docking protocol, for the accuracy of the structure prediction of the bound state. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22926267",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Here, we describe the crystal structure of Pim1 in complex with a newly developed pyrido[4,3-d]pyrimidine-derivative inhibitor (SKI-O-068).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23936194",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Crystallographic and docking data analyses have been undertaken using inhibitor complexes ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22339127",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The crystal structures of Pim1 in apo form and bound with AMPPNP have been solved",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/15808862",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [],
  "exact_answer": "Yes"
}